These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4029127)

  • 1. Infusion strategies to investigate the pharmacokinetics and pharmacodynamics of hypnotic drugs: etomidate as an example.
    Schüttler J; Schwilden H; Stoeckel H
    Eur J Anaesthesiol; 1985 Jun; 2(2):133-42. PubMed ID: 4029127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of the EEG and pharmacodynamic modelling of hypnotic drugs: etomidate as an example.
    Schwilden H; Schüttler J; Stoeckel H
    Eur J Anaesthesiol; 1985 Jun; 2(2):121-31. PubMed ID: 4029126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infusion model for etomidate (author's transl)].
    Schüttler J; Stoeckel H; Wilms M; Schwilden H; Lauven PM
    Anaesthesist; 1980 Dec; 29(12):662-6. PubMed ID: 7212249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetically designed etomidate infusion regimen for hypnosis.
    Fragen RJ; Avram MJ; Henthorn TK; Caldwell NJ
    Anesth Analg; 1983 Jul; 62(7):654-60. PubMed ID: 6859568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentration and E.E.G. after various regimens of etomidate.
    Doenicke A; Löffler B; Kugler J; Suttmann H; Grote B
    Br J Anaesth; 1982 Apr; 54(4):393-400. PubMed ID: 7066137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and pharmacodynamics of brief etomidate infusion in healthy volunteers.
    Kaneda K; Yamashita S; Woo S; Han TH
    J Clin Pharmacol; 2011 Apr; 51(4):482-91. PubMed ID: 20498288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of etomidate in man (author's transl)].
    Schüttler J; Wilms M; Lauven PM; Stoeckel H; Koenig A
    Anaesthesist; 1980 Dec; 29(12):658-61. PubMed ID: 7212248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat.
    Bol CJJG ; Danhof M; Stanski DR; Mandema JW
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1051-8. PubMed ID: 9399976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic modeling of the new steroid hypnotic eltanolone in healthy volunteers.
    Hering WJ; Ihmsen H; Langer H; Uhrlau C; Dinkel M; Geisslinger G; Schüttler J
    Anesthesiology; 1996 Dec; 85(6):1290-9. PubMed ID: 8968176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of etomidate in cats.
    Wertz EM; Benson GJ; Thurmon JC; Tranquilli WJ; Davis LE; Koritz GD
    Am J Vet Res; 1990 Feb; 51(2):281-5. PubMed ID: 2301840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of alfentanil and etomidate in patients and their relation to compressed power spectral analysis of the EEG.
    Freye E; Hartung E; Klatte A; Abel J
    Acta Anaesthesiol Belg; 1983 Jun; 34(2):87-96. PubMed ID: 6412505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of etomidate associated with prolonged i.v. infusion.
    Hebron BS; Edbrooke DL; Newby DM; Mather SJ
    Br J Anaesth; 1983 Apr; 55(4):281-7. PubMed ID: 6340709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of etomidate during an intravenous infusion over 48 hours.
    Hebron BS
    Anaesthesia; 1983 Jul; 38 Suppl():39-43. PubMed ID: 6869754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threshold hypnotic concentration of methohexitone.
    Lauven PM; Schwilden H; Stoeckel H
    Eur J Clin Pharmacol; 1987; 33(3):261-5. PubMed ID: 3691614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etomidate: a pharmacologic profile of a new hypnotic.
    Tornetta FJ; Song S; Smoyer AD
    AANA J; 1980 Dec; 48(6):517-25. PubMed ID: 7468108
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of etomidate in the rat.
    De Paepe P; Belpaire FM; Van Hoey G; Boon PA; Buylaert WA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1048-53. PubMed ID: 10454477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of etomidate. A hypnotic, anticonvulsant and brain protective compound.
    Wauquier A
    Anaesthesia; 1983 Jul; 38 Suppl():26-33. PubMed ID: 6346937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.
    Pejo E; Ge R; Banacos N; Cotten JF; Husain SS; Raines DE
    Anesthesiology; 2012 May; 116(5):1057-65. PubMed ID: 22417966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic data analysis of alfentanil after multiple injections and etomidate-infusion in patients undergoing orthopedic surgery.
    Richter O; Klatte A; Abel J; Freye E; Haag W; Hartung E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):11-5. PubMed ID: 3921471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.